{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:17:46Z","timestamp":1794244666607,"version":"4.9.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.schres.2023.09.029","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T17:08:09Z","timestamp":1695748089000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital"],"prefix":"10.1016","volume":"268","author":[{"given":"Nuree","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungkyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhyeok","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heesoo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeonghoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2023.09.029_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.rpsm.2022.06.001","article-title":"A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levels","volume":"15","author":"Arrojo-Romero","year":"2022","journal-title":"Revista de Psiquiatria y Salud Mental"},{"key":"10.1016\/j.schres.2023.09.029_bb0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2017.12.102","article-title":"A systematic review of clozapine-induced myocarditis","volume":"259","author":"Bellissima","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.schres.2023.09.029_bb0015","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s00213-018-5039-9","article-title":"Benzodiazepines and risk of pneumonia in schizophrenia: a nationwide case\u2013control study","volume":"235","author":"Cheng","year":"2018","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.schres.2023.09.029_bb0020","first-page":"31","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"6","author":"Choudhary","year":"2013","journal-title":"J. Clin. Aesthet. Dermatol."},{"issue":"3","key":"10.1016\/j.schres.2023.09.029_bb0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/17512433.2019.1577134","article-title":"A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults","volume":"12","author":"Cicala","year":"2019","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.1016\/j.schres.2023.09.029_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: a systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2023.09.029_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omx080","article-title":"Clozapine-induced myocarditis","volume":"2018","author":"Datta","year":"2018","journal-title":"Oxford Medical Case Reports"},{"key":"10.1016\/j.schres.2023.09.029_bb0040","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2147\/NDT.S83989","article-title":"Rare and very rare adverse effects of clozapine","author":"De Fazio","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"8","key":"10.1016\/j.schres.2023.09.029_bb0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/17512433.2020.1787831","article-title":"Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review","volume":"13","author":"de Filippis","year":"2020","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.1016\/j.schres.2023.09.029_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.euroneuro.2022.04.009","article-title":"Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases","volume":"60","author":"de Filippis","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2023.09.029_bb0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.rpsm.2021.07.004","article-title":"Clozapine-associated myocarditis in the World Health Organization\u2019s pharmacovigilance database: focus on reports from various countries","volume":"15","author":"De las Cuevas","year":"2022","journal-title":"Revista de Psiquiatria y Salud Mental"},{"issue":"2","key":"10.1016\/j.schres.2023.09.029_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/17425255.2023.2192401","article-title":"Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase","volume":"19","author":"De Las Cuevas","year":"2023","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.schres.2023.09.029_bb0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.24869\/psyd.2022.411","article-title":"Reflections on the complex history of the concept of clozapine-induced inflammation during titration","volume":"34","author":"de Leon","year":"2022","journal-title":"Psychiatr. Danub."},{"issue":"2","key":"10.1016\/j.schres.2023.09.029_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2019-100183","article-title":"Clozapine is strongly associated with the risk of pneumonia and inflammation","volume":"33","author":"de Leon","year":"2020","journal-title":"General Psychiatry"},{"key":"10.1016\/j.schres.2023.09.029_bb0075","series-title":"Data From the World Health Organization\u2019s Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions","first-page":"1","volume":"vol. 46","author":"de Leon","year":"2020"},{"issue":"02","key":"10.1016\/j.schres.2023.09.029_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/a-1625-6388","article-title":"An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels","volume":"55","author":"de Leon","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2023.09.029_bb0085","series-title":"Clozapine Therapy and CYP Genotype","author":"Dean","year":"2021"},{"issue":"11","key":"10.1016\/j.schres.2023.09.029_bb0090","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/brainsci10110840","article-title":"Clozapine: an updated overview of pharmacogenetic biomarkers, risks, and safety\u2014particularities in the context of COVID-19","volume":"10","author":"Dragoi","year":"2020","journal-title":"Brain Sci."},{"issue":"2","key":"10.1016\/j.schres.2023.09.029_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1176\/appi.focus.12.2.235","article-title":"International consensus study of antipsychotic dosing","volume":"12","author":"Gardner","year":"2014","journal-title":"Focus"},{"key":"10.1016\/j.schres.2023.09.029_bb0100","series-title":"The Practitioner\u2019s Guide to Psychoactive Drugs","author":"Gelenberg","year":"2012"},{"issue":"1","key":"10.1016\/j.schres.2023.09.029_bb0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/schbul\/sbac148","article-title":"Clozapine therapy and COVID-19: a systematic review of the prevalence rates, health outcomes, hematological markers, and patient perspectives","volume":"49","author":"Giles","year":"2023","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2023.09.029_bb0110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3126\/nje.v6i4.17254","article-title":"Necessity of oral health intervention in schizophrenic patients-a review","volume":"6","author":"Gupta","year":"2016","journal-title":"Nepal Journal of Epidemiology"},{"issue":"6","key":"10.1016\/j.schres.2023.09.029_bb0115","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00004714-199612000-00013","article-title":"Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea","volume":"16","author":"Hinkes","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2023.09.029_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-1947-0003-0000008574","article-title":"Clozapine-induced interstitial nephritis-a rare but important complication: a case report","volume":"3","author":"Hunter","year":"2009","journal-title":"J Med Case Reports"},{"issue":"8","key":"10.1016\/j.schres.2023.09.029_bb0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in J apan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.schres.2023.09.029_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243437","article-title":"The side effect profile of Clozapine in real world data of three large mental health hospitals","volume":"15","author":"Iqbal","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.schres.2023.09.029_bb0135","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00228-004-0867-4","article-title":"Toxic clozapine serum levels during acute urinary tract infection: a case report","volume":"60","author":"Jecel","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.schres.2023.09.029_bb0140","doi-asserted-by":"crossref","first-page":"411","DOI":"10.9758\/cpn.2021.19.3.411","article-title":"Challenges in prescribing clozapine in the era of COVID-19: a review focused on immunological implications","volume":"19","author":"Jeong","year":"2021","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"key":"10.1016\/j.schres.2023.09.029_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2023.08.001","article-title":"Association between initial pattern of clozapine titration, concentration-to-dose ratio, and incidence of fever in patients with schizophrenia spectrum disorders in a Korean tertiary hospital","author":"Kang","year":"2023","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2023.09.029_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/pcn5.38","article-title":"Successful rechallenge with clozapine after discontinuation due to drug-induced pneumonia: a case report","volume":"1","author":"Kikuchi","year":"2022","journal-title":"Psychiatry and Clinical Neurosciences Reports"},{"issue":"3","key":"10.1016\/j.schres.2023.09.029_bb0155","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/schbul\/sbr202","article-title":"Second-generation antipsychotic medications and risk of pneumonia in schizophrenia","volume":"39","author":"Kuo","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"4_suppl","key":"10.1016\/j.schres.2023.09.029_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1359786810382058","article-title":"Inequalities in healthcare provision for people with severe mental illness","volume":"24","author":"Lawrence","year":"2010","journal-title":"Journal of Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.schres.2023.09.029_bb0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.schres.2016.05.002","article-title":"Reasons for discontinuing clozapine: a cohort study of patients commencing treatment","volume":"174","author":"Legge","year":"2016","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2023.09.029_bb0170","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.psym.2016.11.013","article-title":"Characterization of admission types in medically hospitalized patients prescribed clozapine","volume":"58","author":"Leung","year":"2017","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2023.09.029_bb0175","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.schres.2018.02.058","article-title":"Potentially fatal outcomes associated with clozapine","volume":"199","author":"Li","year":"2018","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2023.09.029_bb0180","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1017\/S0033291719000369","article-title":"The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies","volume":"50","author":"Li","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2023.09.029_bb0185","series-title":"Handbook of Psychiatric Drugs","author":"Lieberman","year":"2006"},{"issue":"1","key":"10.1016\/j.schres.2023.09.029_bb0190","first-page":"139","article-title":"Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence","volume":"58","author":"Miller","year":"1998","journal-title":"Am. Fam. Physician"},{"issue":"4","key":"10.1016\/j.schres.2023.09.029_bb0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3371\/CSRP.MICU.020813","article-title":"C-reactive protein levels in schizophrenia: a review and meta-analysis","volume":"7","author":"Miller","year":"2014","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"5","key":"10.1016\/j.schres.2023.09.029_bb0200","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1097\/MJT.0000000000001532","article-title":"Neutropenia in patients with clozapine-treated schizophrenia: an effect of clozapine or a consequence of SARS-CoV-2 infection? A systematic review","volume":"29","author":"Moga","year":"2022","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.schres.2023.09.029_bb0205","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2147\/NDT.S361405","article-title":"Clozapine and neutropenia in patients with schizophrenia and SARS-CoV-2 infection","volume":"18","author":"Moga","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.schres.2023.09.029_bb0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3371\/CSRP.4.1.4","article-title":"Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world","volume":"4","author":"Mortimer","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.schres.2023.09.029_bb0215","series-title":"Tintinalli's Emergency Medicine","first-page":"1216","article-title":"Benzodiazepines","volume":"vol. 7","author":"Quan","year":"2011"},{"issue":"1\u20133","key":"10.1016\/j.schres.2023.09.029_bb0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","article-title":"Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?","volume":"140","author":"R\u00f8ge","year":"2012","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2023.09.029_bb0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/acps.12827","article-title":"Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study","volume":"137","author":"Rohde","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.schres.2023.09.029_bb0230","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/00048674.2011.572852","article-title":"A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls","volume":"45","author":"Ronaldson","year":"2011","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.schres.2023.09.029_bb0235","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fpsyt.2019.00087","article-title":"Low physical activity and cardiorespiratory fitness in people with schizophrenia: a comparison with matched healthy controls and associations with mental and physical health","volume":"10","author":"Scheewe","year":"2019","journal-title":"Front. Psych."},{"issue":"2","key":"10.1016\/j.schres.2023.09.029_bb0240","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17512433.2021.1877135","article-title":"An update on the complex relationship between clozapine and pneumonia","volume":"14","author":"Schoretsanitis","year":"2021","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.schres.2023.09.029_bb0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(99)00116-4","article-title":"Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist","volume":"42","author":"Song","year":"2000","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2023.09.029_bb0250","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/gps.5048","article-title":"Benzodiazepines or related drugs and risk of pneumonia: a systematic review and meta-analysis","volume":"34","author":"Sun","year":"2019","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2023.09.029_bb0255","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.rpsm.2021.06.002","article-title":"Transient drop in the neutrophil count during COVID-19 regardless of clozapine treatment in patients with mental illness","volume":"15","author":"Vallecillo","year":"2022","journal-title":"Revista de Psiquiatria y Salud Mental"},{"key":"10.1016\/j.schres.2023.09.029_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2019.07.040","article-title":"Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review","volume":"211","author":"Verdoux","year":"2019","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2023.09.029_bb0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/acps.13184","article-title":"Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia","volume":"142","author":"Villasante-Tezanos","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.schres.2023.09.029_bb0270","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/JCP.0000000000001052","article-title":"Estimating the risk of pneumonia in patients with schizophrenia newly receiving clozapine: a nationwide cohort study","volume":"39","author":"Wu","year":"2019","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423003407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423003407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:42:45Z","timestamp":1718091765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423003407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":54,"alternative-id":["S0920996423003407"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.09.029","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}